Prostate Cancer - Results from #25520

In the middle and on the sideline: The experience of spouses of men with prostate cancer - Abstract June 27, 2012

Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy - Abstract June 27, 2012

Biopsy features associated with prostate cancer progression in active surveillance patients: Comparison of three statistical models - Abstract June 27, 2012

Circadian disruption, sleep loss, and prostate cancer risk: A systematic review of epidemiologic studies - Abstract June 26, 2012

Biopsy Gleason score and the duration of testosterone suppression among men treated with external beam radiation and 6 months of combined androgen blockade - Abstract June 26, 2012

Metastatic castrate-resistant prostate cancer: Dawn of a new age of management - Abstract June 26, 2012

Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: Does it happen and does it matter? - Abstract June 26, 2012

HCA intake and prostate cancer risk: Effect modification by genetic variants - Abstract June 26, 2012

Coffee consumption and prostate cancer aggressiveness among African and caucasian Americans in a population-based study - Abstract June 26, 2012

Laparoscopic extended pelvic lymphadenectomy for staging can be performed with limited morbidity and short hospital stay in patients with prostate cancer - Abstract June 26, 2012

Photoselective laser vaporization of the prostate in the treatment of bladder outlet obstruction in advanced-stage prostate cancer：A single-centre experience - Abstract June 26, 2012

Urethral strictures following high-dose-rate brachytherapy for prostate cancer: Analysis of risk factors - Abstract June 26, 2012

Patient-reported long-term rectal function after permanent interstitial brachytherapy for clinically localized prostate cancer - Abstract June 26, 2012

ASCO 2012 - Effect of neoadjuvant abiraterone acetate plus leuprolide acetate on PSA, pathological complete response (pCR), and near pCR in localized high-risk prostate cancer: Results of a randomized phase 2 study - Slide Presentation June 25, 2012

ASCO 2012 - Effect of neoadjuvant abiraterone acetate plus leuprolide acetate on PSA, pathological complete response (pCR), and near pCR in localized high-risk prostate cancer: Results of a randomized phase 2 study - Editor's Commentary June 25, 2012

Quantitative study of focused ultrasound enhanced doxorubicin delivery to prostate tumor in vivo with MRI guidance - Abstract June 25, 2012

The pitfalls of treating anorectal conditions after radiotherapy for prostate cancer - Abstract June 25, 2012

Equivalent normalized total dose estimates in CyberKnife radiotherapy dose delivery in prostate cancer hypofractionation regimens - Abstract June 25, 2012

Impact of edema and seed movement on the dosimetry of prostate seed implants - Abstract June 25, 2012

The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States - Abstract June 25, 2012

Page 1277 of 1436